Month: May 2017

European Medicines Agency to Review RoAccutane Safety

European Medicines Agency to Review RoAccutane Safety

Members of the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) are to meet early June 2017 to Review RoAccutane. This comes after a letter of evidence by Mr. David Roberts, the father of a UK suicide victim, was sent to Parliament encouraging action to be taken on behalf of a group of concerned parents. Parents whose children committed suicide after claiming Roaccuta... »